Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Long-Term-Debt" stands at 39.97 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of Merck & Company Inc's third quarter, the item "Long Term Debt" stands at 39.97 Billion USD. This represents an increase of 17.67 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 14.26 percent compared to the value the year prior.
The 1 year change in percent is 14.26.
The 3 year change in percent is 40.33.
The 5 year change in percent is 51.85.
The 10 year change in percent is 65.68.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Long Term Debt | 905,699,262,464.00 |
![]() | Johnson & Johnson - Long Term Debt | 486,508,953,600.00 |
![]() | AbbVie Inc - Long Term Debt | 399,570,305,024.00 |
![]() | Roche Holding AG - Long Term Debt | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Long Term Debt | 280,205,508,085.11 |